MedPath

Cavion, Inc.

Cavion, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2003-01-01
Employees
11
Market Cap
-
Website
http://www.cavionpharma.com

TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

Phase 1
Completed
Conditions
Glioblastoma Multiforme (GBM)
Interventions
First Posted Date
2014-07-29
Last Posted Date
2019-07-24
Lead Sponsor
Cavion, Inc.
Target Recruit Count
18
Registration Number
NCT02202993
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2012-03-12
Last Posted Date
2019-04-08
Lead Sponsor
Cavion, Inc.
Target Recruit Count
30
Registration Number
NCT01550458
Locations
🇺🇸

Celerion, Inc., Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath